Researcher
Shana Claeys
- Disciplines:Paediatrics and neonatology, Molecular and cell biology, Systems biology, Nursing, Genetics
Affiliations
- Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 2012 → 23 Sep 2018
Projects
1 - 2 of 2
- HBP1 as novel therapeutic target in ALK- and MYCN-driven neuroblastomaFrom1 Oct 2016 → 30 Sep 2017Funding: Nonprofit institution or equivalents
- Functional study of the ALK-F1174 mutation inFrom1 Oct 2012 → 30 Sep 2016Funding: FWO fellowships, BOF - Other initiatives
Publications
1 - 10 of 33
- The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness(2020)
Authors: Liselot Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, et al.
- ALK positively regulates MYCN activity through repression of HBP1 expression(2019)
Authors: Shana Claeys, Geertrui Denecker, Kaat Durinck, Bieke Decaesteker, Liselot Mus, Siebe Loontiens, Suzanne Vanhauwaert, Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.
Pages: 2690 - 2705 - The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Authors: Bieke Decaesteker, Geertrui Denecker, Wouter Van Loocke, Moritz Gartlgruber, Pauline Depuydt, Fanny De Vloed, Shana Claeys, Dries Rombaut, Anton Henssen, Daniel Dreidax, et al.
Number of pages: 1 - TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Authors: Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Fanny De Vloed, Moritz Gartlgruber, Pauline Depuydt, Wouter Van Loocke, Shana Claeys, Dries Rombaut, Anton Henssen, et al.
Number of pages: 1 - A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes(2018)
Authors: Gert Van Peer, Evelien Mets, Shana Claeys, Ines De Punt, Maté Ongenaert, Pieter Mestdagh
- Identification of novel drug targets downstream of activated ALK in neuroblastoma(2018)
Authors: Shana Claeys
- Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma(2018)
Authors: Kristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, Alicia Lundby, Shana Claeys, Katleen De Preter, Franki Speleman, Chiara Francavilla, Jesper V Olsen
- The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Authors: Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Fanny De Vloed, Moritz Gartlgruber, Pauline Depuydt, Wouter Van Loocke, Shana Claeys, Dries Rombaut, Anton Henssen, et al.
Number of pages: 1 - The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2017)
Authors: Bieke Decaesteker, Geertrui Denecker, Wouter Van Loocke, Moritz Gartlgruber, Pauline Depuydt, Fanny De Vloed, Shana Claeys, Dries Rombaut, Anton Henssen, Daniel Dreidax, et al.
Number of pages: 1 - The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma(2017)
Authors: Irina Lambertz, Candy Kumps, Shana Claeys, Geertrui Denecker, Wouter Van Loocke, Christophe Van Neste, Jan Koster, Rogier Versteeg, Johannes Schulte
Number of pages: 1